In fact, the expression of the checkpoint inhibitory molecules PD-1, TIM3, LAG3, and TIGIT has long been associated with lack of T-cell fitness and increased incidence of multiple myeloma relapse (33, 42–45). This evidence concerns the gene HAVCR2 and plasma cell myeloma.